Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
7
×
fda
7
×
life sciences
national blog main
7
×
san francisco blog main
national
national top stories
new york blog main
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
chronic kidney disease
europe blog main
investing
medical device
merck
moderna
abbvie
allergan
What
companies
7
×
ipo
life
new
science
week
bio
drug
roundup
therapeutics
biotech
black
diamond
fda
leading
momentum
raised
research
street
wall
approval
approved
arena’s
arguments
arrival
big
biotechs
bounty
cancer
cig
class
clinic
club
comeback
commercialized
competitors
continue
continued
corner
crop
Language
unset
Current search:
fda
×
" national blog main "
×
" clinical trials "
×
companies
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M